TTD | Drug: D0C3MW

Drug General Information
Drug ID	D0C3MW
Former ID	DIB001027
Drug Name	MBO7133
Indication	Liver cancer [ICD9: 140-229, 155, 203.0; ICD10:C22]		Phase 1/2	[549973]
Company	Metabasis Therapeutics Inc
Target and Pathway
Target(s)	Human DNA	Target Info	Binder	[550613]
References
Ref 549973	Clinical pipeline report, company report or official report of Metabasis Therapeutics (2006).
Ref 550613	Novel Cox-2 Inhibitor for Breast Cancer Therapy. Temple University School of Medicine Philadelphia, Pennsylvania 19140. July 2004.

Drug Information